首页> The Journal of rheumatology> Residual Disease Activity in Canadian Patients With Psoriatic Arthritis Treated With Advanced Therapies: Results From a Multiregistry Analysis (UNISON-PsA).

Residual Disease Activity in Canadian Patients With Psoriatic Arthritis Treated With Advanced Therapies: Results From a Multiregistry Analysis (UNISON-PsA).

导出 LinkOut

翻译打印收藏纠错

第一作者： Dafna D,Gladman

第一单位： D.D. Gladman, MD, University of Toronto, Department of Medicine, Division of Rheumatology, and Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Ontario; dafna.gladman@utoronto.ca.

作者： Dafna D,Gladman ^[1] ; Vinod,Chandran ^[2] ; Cheryl F,Rosen ^[3] ; Sherry,Rohekar ^[4] ; Tristan,Boyd ^[5] ; Lihi,Eder ^[6] ; Proton,Rahman ^[7] ; Jan,Dutz ^[8] ; Jonathan,Chan ^[9] ; Richard P,Haydey ^[10] ; Snezana,Barac ^[10] ; Marie-Claude,Laliberté ^[11] ; Tanya,Girard ^[11] ; Pierre-André,Fournier ^[11] ; Mitchell,Sutton ^[12] ; Daniel,Pereira ^[12] ; Tina,Chim ^[12] ; Louis,Coupal ^[13] ; Denis,Choquette ^[13]

作者单位： D.D. Gladman, MD, University of Toronto, Department of Medicine, Division of Rheumatology, and Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Ontario; dafna.gladman@utoronto.ca. ^[1] V. Chandran, MBBS, MD, DM, PhD, University of Toronto, Department of Medicine, Division of Rheumatology, Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario. ^[2] C.F. Rosen, MD, Division of Dermatology, Department of Medicine, University of Toronto, and Division of Dermatology, Toronto Western Hospital, Toronto, Ontario. ^[3] S. Rohekar, MD, Division of Rheumatology, Western University, London, Ontario. ^[4] T. Boyd, MD, Division of Rheumatology, Western University, and Division of Rheumatology, St. Joseph's Hospital, London, Ontario. ^[5] L. Eder, MD, PhD, Division of Rheumatology, Women's College Hospital, and Department of Medicine, University of Toronto, Toronto, Ontario. ^[6] P. Rahman, MD, Department of Medicine, Memorial University, St. John's, Newfoundland. ^[7] J. Dutz, MD, Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia. ^[8] J. Chan, MD, Department of Medicine, Division of Rheumatology, University of British Columbia, and Arthritis Research Canada, Vancouver, British Columbia. ^[9] R.P. Haydey, MD, S. Barac, MD, Winnipeg Clinic, Winnipeg, Manitoba. ^[10] M.C. Laliberté, PhD, T. Girard, PhD, P.A. Fournier, MSc, MBA, AbbVie Corp., St. Laurent, Quebec. ^[11] M. Sutton, MSc, D. Pereira, BSc, T. Chim, MSc, Center for Prognosis Studies in the Rheumatic Diseases, Psoriatic Disease Program, Toronto Western Hospital, University Health Network, Toronto, Ontario. ^[12] L. Coupal, MSc, D. Choquette, MD, Institut de Rhumatologie de Montréal, CHUM, University of Montreal, Montreal, Quebec, Canada. ^[13]

关键词 advanced therapy antirheumatic agents burden of disease psoriatic arthritis residual disease activity